Diagnosis and management of prediabetes: a review
Echouffo-Tcheugui JB, Perreault L, Ji L, Dagogo-Jack S
JAMA. 2023;329(14):1206-1216.
Leggi
Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open-label, two-period crossover trial
Laugesen C, Ranjan AG, Schmidt S, Nørgaard K
Diabetologia. Pub. online 11 Apr 2023.
Leggi
Protocollo CONI, FeSDI, Intergruppo parlamentare
Cari Soci, siamo lieti di comunicarvi che è stato siglato giovedì 13 aprile tra il CONI, l’Intergruppo Parlamentare Obesità e Diabete e la Federazione Società Scientifica di Diabetologia (FESDI), costituita dalla Società Italiana di Diabetologia (SID) e dall’Associazione Medici Diabetologici (AMD), un Protocollo d’intesa per la promozione di stili di vita…
Leggi
Efficacy and safety of once‐weekly efpeglenatide in people with suboptimally controlled type 2 diabetes: the AMPLITUDE‐D, AMPLITUDE‐L and AMPLITUDE‐S randomised controlled trials
Aroda VR, Frias JP, Ji L, et al.
Diabetes Obes Metab. Pub. online 4 Apr 2023.
Leggi
Does chronic low-dose aspirin use benefit bone health? A cross-sectional study on patients with type 2 diabetes mellitus
Zhang L, Ji X, Chen J, et al.
BMC Endocr Disord. 2023;23(1):79.
Leggi
Safety and efficacy of an adaptive bolus calculator for type 1 diabetes: a randomised control cross over study
Unsworth R, Armiger R, Jugnee N, et al.
Diabetes Technol Ther. Pub. online 5 Apr 2023.
Leggi
Advanced lipoprotein profile identifies atherosclerosis better than conventional lipids in type 1 diabetes at high cardiovascular risk
Serés-Noriega T, Ortega E, Giménez M, et al.
NMCD. Pub. online 4 Apr 2023.
Leggi
Bergenstal RM, Hachmann-Nielsen E, Kvist K, et al. Diabetes Technol Ther. Pub. online 5 Apr 2023.
Bergenstal RM, Hachmann-Nielsen E, Kvist K, et al.
Diabetes Technol Ther. Pub. online 5 Apr 2023.
Leggi
Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: integrated analysis from the CANVAS Program and CREDENCE trial
Yi TW, Wong MMY, Neuen BL, et al.
Diabetes Obes Metab. Pub. online 27 Mar 2023.
Leggi